EAS Academy is the Society’s resource of online lectures, presentations and talks, recorded at our congress, courses and webinars. Search among hundreds of talks from leading speakers in the field. EAS members have access to the whole EAS Academy archive. 

Lipid management in Europe the SANTORINI study
Kausik Ray
May 21, 2023 | 91th EAS Congress 2023, Re-thinking Lipid Management in Patients with High and Very High Cardiovascular Risk
Bempedoic acid in clinical practice updates from the MILOS study
May 21, 2023 | 91th EAS Congress 2023, Re-thinking Lipid Management in Patients with High and Very High Cardiovascular Risk
Panel Discussion: Re-thinking Lipid Management in Patients with High and Very High Cardiovascular Risk
Kausik Ray, Lale Tokgözoğlu, Luis Masana, Stephen Nicholls
May 21, 2023 | Re-thinking Lipid Management in Patients with High and Very High Cardiovascular Risk, 91th EAS Congress 2023
Combination lipid-modifying therapy in high- and very-high-risk patients
Luis Masana
May 21, 2023 | 91th EAS Congress 2023, Re-thinking Lipid Management in Patients with High and Very High Cardiovascular Risk
Novel add-on therapeutic options for LDL-C management
Stephen Nicholls
May 21, 2023 | 91th EAS Congress 2023, Re-thinking Lipid Management in Patients with High and Very High Cardiovascular Risk
TG vs apo B reduction
Brian Ference
May 21, 2023 | 91th EAS Congress 2023, Elevated triglycerides and reduction of CV risk: What did we learn after REDUCE-IT?
Modern approach to dyslipidemia
Peter Libby
May 22, 2023 | 91th EAS Congress 2023, Integrating the many players of cardiovascular risk
FIBRATES The PROMINENT trial
Kausik Ray
May 21, 2023 | 91th EAS Congress 2023, Elevated triglycerides and reduction of CV risk: What did we learn after REDUCE-IT?
Recent trials with Omega 3 lessons to be learned
Alberto Zambon
May 21, 2023 | 91th EAS Congress 2023, Elevated triglycerides and reduction of CV risk: What did we learn after REDUCE-IT?
EPA Mechanism(s) of action
Chris Packard
May 21, 2023 | 91th EAS Congress 2023, Elevated triglycerides and reduction of CV risk: What did we learn after REDUCE-IT?